[1] Moldoveanu Z，Wyatt RJ，Lee JY，et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels [J]. Kidney Int，2007，71(11)：1149-1154. [2] Zhao N，Hou P，Lv J，et al. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression [J]. Kidney Int，2012，82(7)：790-796. [3] Kiryluk K，Moldoveanu Z，Sanders JT， et al. Aberrant glycosylation of IgA1 is inherited in pediatric IgA nephropathy and Henoch-Schonlein purpura nephritis [J]. Kidney Int，2011，80(1)：79-87. [4] 邹敏书，余健等.IgA肾病及过敏性紫癜肾炎患儿血清半乳糖缺乏的IgA1测定的临床意义 [J]. 华南国防医学杂志，2012，26(6)：542-556. [5] Gharavi AG，Moldoveanu Z，Wyatt RJ，et al. Aberrant IgAl glycosylation is inherited in familial and sporadic IgA nephropathy [J].J Am Soc Nephrol，2008，19(5)：1008-1014． [6] Iwase H，Ishii-Karak asa I，Fujii E，et al. Analysis of glycoform of O-glycan from human myeloma immnunoglobulin A1 by gas-phase hydrazinolysis is following pyridylamination of oligosaccharides [J]. Anal Biochem，1992，206(1)：202-205. [7] Nakata J，Suzuki Y，Suzuki H，et al. Experimental evidence of cell dissemination playing a role in pathogenesis of IgA nephropathy in multiple lymphoid organs [J]. Nephrol Dial Transplant，2013，28(2)：320-326. [8] Suzuki H，Fan R，Zhang Z，et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity [J].J Clin Invest 2009，119(6)： 1668-1677. [9] Tomana M，Novak J，Jullian BA，et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies [J].J Clin Invest，1999，104(1)：73-81. [10] Crisp HC，Quinn JM. Quantitative immunoglobulins in adulthood[J]. Allergy Asthma Proc，2009，30(6)：649-654. [11] 薛辛东儿科学（第8版）[M]，2011. [12] Lai KN．Pathogenesis of IgA nephropathy[J]．Nat Rev Nephrol，2012，8(5)：275-283. [13] Boyd JK，Cheung CK，Molyneux K，et al．An upaate on the pathogenesis and treatment of IgA nephropathy[J].Kidney Int，2012，81(9)：833—843. [14] 邹敏书，余健等.IgA肾病的病因进展及治疗现状[J].临床肾脏病杂志，2013，13(2)：91-93. [15] Floege J. The pathogenesis of IgAnephropathy： what is new and how does it change therapeutic approaches?[J].Am J Kidney Dis，2011，58(6)：992-1004. [16] Moura IC，Benhamou M，Launay P，et al. The glomerular response to IgA deposition in IgA nephropathy[J].Semin Nephrol，2008，28(1)：88-95. [17] Pillai U，Balabhadraputani K，Bhat Z. Immunoglobulin a nephropathy： a review of current literature on emerging pathophysiolopy[J]. Am J Med Sci，2014，347(3)：249-253. [18] Hastings MC，Moldoveanu Z，Suzuki H，et al. Biomarkers in IgA nephropathy： relationship to pathogenetic hits[J]. Expert Opin Med Diagn，2013，7(6)：615-627. [19] Shimozato S，Hiki Y，Odani H，et al. Serum undergalactosylated IgA1 is increased in Japanese patients with IgA nephropathy[J].Nephrol Dial Transplant，2008，23(6)：1931-1939. [20] Wang HV，Chang LW，Brixius K，et al. Integrin-linked kinase stabilizes myotendinous junctiona and protects muscle from stress-induced damage [J].J Cell Biol，2008，180(5)：1037-1049. [21] Coppo R，Basolo B，Piccoli G，et al. IgA and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schoenlein purpura nephritis[J]. Clinic Exp Immunol，1984，57(3)：583-590. [22] Levinsky RJ，Barratt TM. IgA immune complexes in Henoch-Schoenlein purpura[J]. Lancet，1979，2(8152)：1100-1103. [23] Leu KK，Wyatt RJ，Moldoveanu Z，et al. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schoenlein purpura[J]. Pediatr Nephrol，2007，22(12)：2067-2072. [24] Lavigne KA，Woodford SY，Barker CV，et al. Familial IgA nephropathy in southeastern Kentucky[J].Clin Nephrol， 2010，73(2)：115-121. [25] Shimozato S，Hiki Y，Odani H，et al. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy[J]. Nephrol Dial Transplant，2008，23(6)： 1931-1939. [26] Hastings MC，Moldoveanu Z，Julian BA，et al. Galactose-deficient IgA1 in African Ameicans with IgA nephropathy：serum levels and heritability[J]. Clin J Am Soc Nephrol，2010，5(11)：2069-2074.
